InvestSMART

Oceania Healthcare Limited (ASX:OCA)

ALERT: Price-sensitive ASX Announcement for OCA
Current share price for OCA : $0.620 0.07 (12.73%)+
Release
22 May 2026 7:30AM
Price at Release
$0.550
Full Release
download
Summary
Oceania Healthcare Limited's FY26 Investor Presentation highlights significant financial and operational achievements despite challenging market conditions. The company reported a record sales volume of 603 units, a 16% increase from FY25, while reducing unsold development stock by 34%. Underlying EBITDA grew by 20.2% to $97.7 million, driven by improved care profitability and cost-saving measures. Oceania also achieved a 64% improvement in free cash flow from operations and reduced net debt by 19.3% to $506.7 million. The company’s portfolio remains well-balanced with ongoing developments and divestments. Looking forward, Oceania aims to continue its strategic focus on enhancing portfolio returns and achieving positive free cash flow.
Key Points
  • Record sales volumes of 603 units, up 16% from FY25.
  • Underlying EBITDA increased by 20.2% to $97.7 million.
  • Unsold development stock reduced by 34% to $227 million.
  • Net debt reduced by 19.3% to $506.7 million.
  • Free cash flow from operations improved by 64%.
  • Portfolio remains balanced with strategic divestments and developments.
  • Focus on achieving positive free cash flow and enhancing portfolio returns in FY27.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.